Matthew D. currently serves as a QC Scientist IV specializing in Assay Tech Transfer & Development at 4basebio since March 2025. Prior experience includes roles as a Senior Scientist in Analytical Development and Quality Control at Rentschler Biopharma from January 2022 to March 2025, and as Quality Control Scientist II and I at TCR² Therapeutics Inc. from July 2020 to December 2021. Additionally, Matthew worked as a Quality Control Validation Scientist and Analytical Scientist at TC BioPharm Limited between June 2018 and June 2020, optimizing T-cell assays and performing release testing under GMP standards. Earlier in career, Matthew was a Research Assistant at the University of Glasgow and completed a PhD in Cancer Studies there from 2013 to 2017, focusing on high throughput screening for potential driver genes in Head and Neck Squamous Cell Carcinoma. Matthew earned a BSc in Biomedical Sciences from Queen's University Belfast (2010-2013).
This person is not in the org chart
This person is not in any teams
This person is not in any offices